6/27/2023CDE Solicits Comments on the Technical Guidelines for Patient Report O...

6/26/2023Snapshot of Import Drugs Approved by NMPA in 2022 (1)

6/26/2023CDE Solicits Comments on the Technical Guidelines for Non-clinical Res...

6/26/2023CDE Solicits Comments on the Q&As on Pharmaceutical Change Research Re...

6/26/2023NMPA Issues the List of Reference Formulations for GQCE Studies (69th ...

6/25/2023CDE Issues on the Technical Guidelines for New Drug Benefit-Risk Asses...

6/21/2023NMPA Issues Announcement on Relevant Matters Related to Implementation...

6/21/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...

6/21/2023CDE Issues on the Technical Guidelines for Clinical Trials of Human-De...

6/20/2023CDE Solicits Comments on the Technical Requirements for Generic Pharma...

6/20/2023NMPA Restores Import, Sales and Use of Dr. Reddy's Quetiapine Fumarate

6/20/2023NMPA to Officially Join PIC/S in 2023 Following Pre-Accession Process

6/16/2023U.S. FDA and PhRMA Delegations Visited China, Met by Chinese Officials

6/13/2023NMPA Announces Package Insert Revision of Betahistine Preparations

6/9/2023CDE Issues the Technical Guidelines for Clinical Trial Design of New N...

6/9/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (71...

6/9/2023NHC Solicits Comments on the Proposed Biosafety Standards for Vaccine ...

6/2/2023FDA Permits Temporary Import of Unapproved Chinese Cancer Drug to Alle...

6/2/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (70...

6/1/2023China Issues the Implementing Rules for Regulations on the Management ...

5/31/2023NMPA Issues the Procedure for Addition of Pediatric Drug Information t...

5/31/2023NMPA Announces OTC Switch of Metronidazole Chlorhexidine Solution (Con...

5/29/2023CDE Seeks Comments on Draft ICH Guidelines E6 (R3) for GCP

5/26/2023NHC Publicizes the List of Pediatric Drugs Encouraged for R&D and Regi...

5/24/2023CDE Solicits Comments on the Draft Announcement for Generic Research o...

5/24/2023NMPA Solicits Comments on New Document on Strengthening Regulation of ...

5/23/2023NMPA and NHC Issue Notice to Strengthen Regulation of Tramadol and Oth...

5/22/2023PhIIC Reviews Import Oncology and Anti-infective Drug Approvals in 202...

5/16/2023NMPA and BfArM Sign Joint Declaration of Intent

5/12/2023NMPA Issues the List of Reference Formulations for GQCE Studies (68th ...

Page:8/9 Total number of articles:257: [First][<<] [5] [6] [7] [8] [9] [>>] [End]